Transvenous lead extraction (TLE) was becoming more common, and more complicated devices were implanted. TLE was now a standard component of cardiac device maintenance, and up-to-date information on the safety and efficacy of TLE using modern technologies and procedures was critical for making management decisions regarding noninfectious indications for lead extraction. Researchers gave a current, prospective review of TLE at the high-volume cardiac center. All patients who underwent TLE between June 2016 and June 2019 were included in the local database, and baseline clinical data, procedural data, and outcome data were gathered. During the study period, 561 leads were explanted (n=153) or removed (n=408) from 341 patients. The average age of the patients was somewhere between 65±17 years, and the majority were male (71%). Lead failure was the most prevalent reason for lead removal (45.2%, n=154), followed by infection of the pocket or device (29.3%, n=100). Complete success was obtained in 96.4% (n=541) of the leads, clinical success in an additional 2.1% (n=12), and only 1.4% (n=8) of the leads failed. The total rate of complications was 0.9% (3/341) for serious problems and 1.5% (5/341) for minor complications. There were no mortalities. In conclusion, the findings implied that the safety profile and success rates of lead extraction performed by skilled operators continue to improve. The rate of significant complications was now less than 1%.